According to the Latest Research Report,, the global market for Molecular Diagnostics Point of Care should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Molecular Diagnostics Point of Care market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Molecular Diagnostics Point of Care market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

By segment, Tumor grew percent to account for percent of the total market sales, and Hematology grew percent.

The Molecular Diagnostics Point of Care enables physicians to improve the standard of care by combining rapid diagnosis with treatment decisions during the first patient visit.

This report studies and analyses global Molecular Diagnostics Point of Care status and future trends, to help determine the Molecular Diagnostics Point of Care market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Molecular Diagnostics Point of Care, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights

(1) Global Molecular Diagnostics Point of Care market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)

(2) Global Molecular Diagnostics Point of Care by company, revenue, market share and industry ranking 2018-2023, (US$ million)

(3) China Molecular Diagnostics Point of Care by company, revenue, market share and industry ranking 2018-2023, (US$ million)

(4) Global Molecular Diagnostics Point of Care key consuming regions, consumption value and demand structure

(5) Molecular Diagnostics Point of Care industry chains, upstream, midstream and downstream

Market segment by players, this report covers

Abbott Laboratories

Abaxis

Bayer Healthcare

Bio-Rad Laboratories

Becton Dickinson and Company

Binx Health

BioMerieux

Co-Diagnostics

DanaherCorporation

Dako

F. Hoffmann

OraSure Technologies

Roche Diagnostics

Nipro Diagnostics

Genestat

Meridian Bioscience

Molbio Diagnostics

Siemens Healthcare

Thermo Fisher Scientific

Visby Medical

Wuhan Easy Diagnosis Biomedicine

Beijing Tiandz

Beijing Content

Market segment by Type, covers

Assays and Kits

Instruments and Analyzers

Software and Services

Others

Market segment by Application, can be divided into

Tumor

Hematology

Endocrinology

Infectious Disease

Others

Key Regions Covered in This Report Are:

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

The Report Consists of The Following Points:

Chapter 1: to describe Molecular Diagnostics Point of Care product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.

Chapter 2: Global Molecular Diagnostics Point of Care market share and ranking of major manufacturers, revenue, 2018-2023

Chapter 3: China Molecular Diagnostics Point of Care market share and ranking of major manufacturers, revenue, 2018-2023

Chapter 4: Molecular Diagnostics Point of Care industry chain, upstream, medium-stream, and downstream.

Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029

Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029

Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029

Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029

Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.

Chapter 10: Conclusions

1 Market Overview

1.1 Molecular Diagnostics Point of Care Definition

1.2 Global Molecular Diagnostics Point of Care Market Size and Forecast

1.3 China Molecular Diagnostics Point of Care Market Size and Forecast

1.4 China Percentage in Global Market

1.5 Molecular Diagnostics Point of Care Market Size: China VS Global Growth Rate, 2018-2029

1.6 Molecular Diagnostics Point of Care Market Dynamics

1.6.1 Molecular Diagnostics Point of Care Market Drivers

1.6.2 Molecular Diagnostics Point of Care Market Restraints

1.6.3 Molecular Diagnostics Point of Care Industry Trends

1.6.4 Molecular Diagnostics Point of Care Industry Policy

2 Global Leading Players and Market Share

2.1 By Revenue of Molecular Diagnostics Point of Care, Global Market Share by Company, 2018-2023

2.2 Global Molecular Diagnostics Point of Care Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.3 Global Molecular Diagnostics Point of Care Concentration Ratio

2.4 Global Molecular Diagnostics Point of Care Mergers & Acquisitions, Expansion Plans

2.5 Global Molecular Diagnostics Point of Care Major Companies Product Type

2.6 Head Office and Molecular Diagnostics Point of Care Production Site of Key Manufacturer

3 China Leading Players, Market Share and Ranking

3.1 By Revenue of Molecular Diagnostics Point of Care, China Market Share by Company, 2018-2023

3.2 China Molecular Diagnostics Point of Care Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis

4.1 Molecular Diagnostics Point of Care Industry Chain

4.2 Molecular Diagnostics Point of Care Upstream Analysis

4.2.1 Molecular Diagnostics Point of Care Core Raw Materials

4.2.2 Main Manufacturers of Molecular Diagnostics Point of Care Core Raw Materials

4.3 Midstream Analysis

4.4 Downstream Analysis

4.5 Molecular Diagnostics Point of Care Production Mode

4.6 Molecular Diagnostics Point of Care Procurement Model

4.7 Molecular Diagnostics Point of Care Industry Sales Model and Sales Channels

4.7.1 Molecular Diagnostics Point of Care Sales Model

4.7.2 Molecular Diagnostics Point of Care Typical Distributors

5 Sights by Type

5.1 Molecular Diagnostics Point of Care Classification

5.1.1 Assays and Kits

5.1.2 Instruments and Analyzers

5.1.3 Software and Services

5.1.4 Others

5.2 By Type, Global Molecular Diagnostics Point of Care Consumption Value & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Molecular Diagnostics Point of Care Consumption Value, 2018-2029

6 Sights by Application

6.1 Molecular Diagnostics Point of Care Segment by Application

6.1.1 Tumor

6.1.2 Hematology

6.1.3 Endocrinology

6.1.4 Infectious Disease

6.1.5 Others

6.2 By Application, Global Molecular Diagnostics Point of Care Consumption Value & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Molecular Diagnostics Point of Care Consumption Value, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Molecular Diagnostics Point of Care Consumption Value, 2018 VS 2022 VS 2029

7.2 By Region, Global Molecular Diagnostics Point of Care Consumption Value, 2018-2029

7.3 North America

7.3.1 North America Molecular Diagnostics Point of Care & Forecasts, 2018-2029

7.3.2 By Country, North America Molecular Diagnostics Point of Care Market Size Market Share

7.4 Europe

7.4.1 Europe Molecular Diagnostics Point of Care Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Molecular Diagnostics Point of Care Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Molecular Diagnostics Point of Care Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Molecular Diagnostics Point of Care Market Size Market Share

7.6 South America

7.6.1 South America Molecular Diagnostics Point of Care Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Molecular Diagnostics Point of Care Market Size Market Share

7.7 Middle East & Africa

8 Sales Sights by Country Level

8.1 By Country, Global Molecular Diagnostics Point of Care Market Size & CAGR, 2018 VS 2022 VS 2029

8.2 By Country, Global Molecular Diagnostics Point of Care Consumption Value, 2018-2029

8.3 U.S.

8.3.1 U.S. Molecular Diagnostics Point of Care Market Size, 2018-2029

8.3.2 By Type, U.S. Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.3.3 By Application, U.S. Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Molecular Diagnostics Point of Care Market Size, 2018-2029

8.4.2 By Type, Europe Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.4.3 By Application, Europe Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.5 China

8.5.1 China Molecular Diagnostics Point of Care Market Size, 2018-2029

8.5.2 By Type, China Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.5.3 By Application, China Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Molecular Diagnostics Point of Care Market Size, 2018-2029

8.6.2 By Type, Japan Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.6.3 By Application, Japan Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Molecular Diagnostics Point of Care Market Size, 2018-2029

8.7.2 By Type, South Korea Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.7.3 By Application, South Korea Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Molecular Diagnostics Point of Care Market Size, 2018-2029

8.8.2 By Type, Southeast Asia Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.8.3 By Application, Southeast Asia Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.9 India

8.9.1 India Molecular Diagnostics Point of Care Market Size, 2018-2029

8.9.2 By Type, India Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.9.3 By Application, India Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.10 Middle East & Africa

8.10.1 Middle East & Africa Molecular Diagnostics Point of Care Market Size, 2018-2029

8.10.2 By Type, Middle East & Africa Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

8.10.3 By Application, Middle East & Africa Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

9 Company Profile

9.1 Abbott Laboratories

9.1.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

9.1.2 Abbott Laboratories Company Profile and Main Business

9.1.3 Abbott Laboratories Molecular Diagnostics Point of Care Models, Specifications and Application

9.1.4 Abbott Laboratories Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.1.5 Abbott Laboratories Recent Developments

9.2 Abaxis

9.2.1 Abaxis Company Information, Head Office, Market Area and Industry Position

9.2.2 Abaxis Company Profile and Main Business

9.2.3 Abaxis Molecular Diagnostics Point of Care Models, Specifications and Application

9.2.4 Abaxis Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.2.5 Abaxis Recent Developments

9.3 Bayer Healthcare

9.3.1 Bayer Healthcare Company Information, Head Office, Market Area and Industry Position

9.3.2 Bayer Healthcare Company Profile and Main Business

9.3.3 Bayer Healthcare Molecular Diagnostics Point of Care Models, Specifications and Application

9.3.4 Bayer Healthcare Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.3.5 Bayer Healthcare Recent Developments

9.4 Bio-Rad Laboratories

9.4.1 Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position

9.4.2 Bio-Rad Laboratories Company Profile and Main Business

9.4.3 Bio-Rad Laboratories Molecular Diagnostics Point of Care Models, Specifications and Application

9.4.4 Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.4.5 Bio-Rad Laboratories Recent Developments

9.5 Becton Dickinson and Company

9.5.1 Becton Dickinson and Company Company Information, Head Office, Market Area and Industry Position

9.5.2 Becton Dickinson and Company Company Profile and Main Business

9.5.3 Becton Dickinson and Company Molecular Diagnostics Point of Care Models, Specifications and Application

9.5.4 Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.5.5 Becton Dickinson and Company Recent Developments

9.6 Binx Health

9.6.1 Binx Health Company Information, Head Office, Market Area and Industry Position

9.6.2 Binx Health Company Profile and Main Business

9.6.3 Binx Health Molecular Diagnostics Point of Care Models, Specifications and Application

9.6.4 Binx Health Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.6.5 Binx Health Recent Developments

9.7 BioMerieux

9.7.1 BioMerieux Company Information, Head Office, Market Area and Industry Position

9.7.2 BioMerieux Company Profile and Main Business

9.7.3 BioMerieux Molecular Diagnostics Point of Care Models, Specifications and Application

9.7.4 BioMerieux Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.7.5 BioMerieux Recent Developments

9.8 Co-Diagnostics

9.8.1 Co-Diagnostics Company Information, Head Office, Market Area and Industry Position

9.8.2 Co-Diagnostics Company Profile and Main Business

9.8.3 Co-Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application

9.8.4 Co-Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.8.5 Co-Diagnostics Recent Developments

9.9 DanaherCorporation

9.9.1 DanaherCorporation Company Information, Head Office, Market Area and Industry Position

9.9.2 DanaherCorporation Company Profile and Main Business

9.9.3 DanaherCorporation Molecular Diagnostics Point of Care Models, Specifications and Application

9.9.4 DanaherCorporation Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.9.5 DanaherCorporation Recent Developments

9.10 Dako

9.10.1 Dako Company Information, Head Office, Market Area and Industry Position

9.10.2 Dako Company Profile and Main Business

9.10.3 Dako Molecular Diagnostics Point of Care Models, Specifications and Application

9.10.4 Dako Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.10.5 Dako Recent Developments

9.11 F. Hoffmann

9.11.1 F. Hoffmann Company Information, Head Office, Market Area and Industry Position

9.11.2 F. Hoffmann Company Profile and Main Business

9.11.3 F. Hoffmann Molecular Diagnostics Point of Care Models, Specifications and Application

9.11.4 F. Hoffmann Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.11.5 F. Hoffmann Recent Developments

9.12 OraSure Technologies

9.12.1 OraSure Technologies Company Information, Head Office, Market Area and Industry Position

9.12.2 OraSure Technologies Company Profile and Main Business

9.12.3 OraSure Technologies Molecular Diagnostics Point of Care Models, Specifications and Application

9.12.4 OraSure Technologies Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.12.5 OraSure Technologies Recent Developments

9.13 Roche Diagnostics

9.13.1 Roche Diagnostics Company Information, Head Office, Market Area and Industry Position

9.13.2 Roche Diagnostics Company Profile and Main Business

9.13.3 Roche Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application

9.13.4 Roche Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.13.5 Roche Diagnostics Recent Developments

9.14 Nipro Diagnostics

9.14.1 Nipro Diagnostics Company Information, Head Office, Market Area and Industry Position

9.14.2 Nipro Diagnostics Company Profile and Main Business

9.14.3 Nipro Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application

9.14.4 Nipro Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.14.5 Nipro Diagnostics Recent Developments

9.15 Genestat

9.15.1 Genestat Company Information, Head Office, Market Area and Industry Position

9.15.2 Genestat Company Profile and Main Business

9.15.3 Genestat Molecular Diagnostics Point of Care Models, Specifications and Application

9.15.4 Genestat Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.15.5 Genestat Recent Developments

9.16 Meridian Bioscience

9.16.1 Meridian Bioscience Company Information, Head Office, Market Area and Industry Position

9.16.2 Meridian Bioscience Company Profile and Main Business

9.16.3 Meridian Bioscience Molecular Diagnostics Point of Care Models, Specifications and Application

9.16.4 Meridian Bioscience Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.16.5 Meridian Bioscience Recent Developments

9.17 Molbio Diagnostics

9.17.1 Molbio Diagnostics Company Information, Head Office, Market Area and Industry Position

9.17.2 Molbio Diagnostics Company Profile and Main Business

9.17.3 Molbio Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application

9.17.4 Molbio Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.17.5 Molbio Diagnostics Recent Developments

9.18 Siemens Healthcare

9.18.1 Siemens Healthcare Company Information, Head Office, Market Area and Industry Position

9.18.2 Siemens Healthcare Company Profile and Main Business

9.18.3 Siemens Healthcare Molecular Diagnostics Point of Care Models, Specifications and Application

9.18.4 Siemens Healthcare Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.18.5 Siemens Healthcare Recent Developments

9.19 Thermo Fisher Scientific

9.19.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position

9.19.2 Thermo Fisher Scientific Company Profile and Main Business

9.19.3 Thermo Fisher Scientific Molecular Diagnostics Point of Care Models, Specifications and Application

9.19.4 Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.19.5 Thermo Fisher Scientific Recent Developments

9.20 Visby Medical

9.20.1 Visby Medical Company Information, Head Office, Market Area and Industry Position

9.20.2 Visby Medical Company Profile and Main Business

9.20.3 Visby Medical Molecular Diagnostics Point of Care Models, Specifications and Application

9.20.4 Visby Medical Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.20.5 Visby Medical Recent Developments

9.21 Wuhan Easy Diagnosis Biomedicine

9.21.1 Wuhan Easy Diagnosis Biomedicine Company Information, Head Office, Market Area and Industry Position

9.21.2 Wuhan Easy Diagnosis Biomedicine Company Profile and Main Business

9.21.3 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Models, Specifications and Application

9.21.4 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.21.5 Wuhan Easy Diagnosis Biomedicine Recent Developments

9.22 Beijing Tiandz

9.22.1 Beijing Tiandz Company Information, Head Office, Market Area and Industry Position

9.22.2 Beijing Tiandz Company Profile and Main Business

9.22.3 Beijing Tiandz Molecular Diagnostics Point of Care Models, Specifications and Application

9.22.4 Beijing Tiandz Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.22.5 Beijing Tiandz Recent Developments

9.23 Beijing Content

9.23.1 Beijing Content Company Information, Head Office, Market Area and Industry Position

9.23.2 Beijing Content Company Profile and Main Business

9.23.3 Beijing Content Molecular Diagnostics Point of Care Models, Specifications and Application

9.23.4 Beijing Content Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.23.5 Beijing Content Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Molecular Diagnostics Point of Care Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Molecular Diagnostics Point of Care Market Restraints

Table 3. Molecular Diagnostics Point of Care Market Trends

Table 4. Molecular Diagnostics Point of Care Industry Policy

Table 5. Global Molecular Diagnostics Point of Care Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Molecular Diagnostics Point of Care Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Molecular Diagnostics Point of Care Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Molecular Diagnostics Point of Care Mergers & Acquisitions, Expansion Plans

Table 9. Global Molecular Diagnostics Point of Care Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Molecular Diagnostics Point of Care Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 12. China Molecular Diagnostics Point of Care Revenue Market Share by Company, 2018-2023

Table 13. Global Key Players of Molecular Diagnostics Point of Care Upstream (Raw Materials)

Table 14. Global Molecular Diagnostics Point of Care Typical Customers

Table 15. Molecular Diagnostics Point of Care Typical Distributors

Table 16. By Type, Global Molecular Diagnostics Point of Care Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Application, Global Molecular Diagnostics Point of Care Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Molecular Diagnostics Point of Care Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 19. By Region, Global Molecular Diagnostics Point of Care Consumption Value, 2018-2029, US$ Million

Table 20. By Country, Global Molecular Diagnostics Point of Care Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 21. By Country, Global Molecular Diagnostics Point of Care Consumption Value, 2018-2029, US$ Million

Table 22. By Country, Global Molecular Diagnostics Point of Care Consumption Value Market Share, 2018-2029

Table 23. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

Table 24. Abbott Laboratories Company Profile and Main Business

Table 25. Abbott Laboratories Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 26. Abbott Laboratories Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 27. Abbott Laboratories Recent Developments

Table 28. Abaxis Company Information, Head Office, Market Area and Industry Position

Table 29. Abaxis Company Profile and Main Business

Table 30. Abaxis Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 31. Abaxis Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 32. Abaxis Recent Developments

Table 33. Bayer Healthcare Company Information, Head Office, Market Area and Industry Position

Table 34. Bayer Healthcare Company Profile and Main Business

Table 35. Bayer Healthcare Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 36. Bayer Healthcare Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 37. Bayer Healthcare Recent Developments

Table 38. Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position

Table 39. Bio-Rad Laboratories Company Profile and Main Business

Table 40. Bio-Rad Laboratories Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 41. Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 42. Bio-Rad Laboratories Recent Developments

Table 43. Becton Dickinson and Company Company Information, Head Office, Market Area and Industry Position

Table 44. Becton Dickinson and Company Company Profile and Main Business

Table 45. Becton Dickinson and Company Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 46. Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 47. Becton Dickinson and Company Recent Developments

Table 48. Binx Health Company Information, Head Office, Market Area and Industry Position

Table 49. Binx Health Company Profile and Main Business

Table 50. Binx Health Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 51. Binx Health Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 52. Binx Health Recent Developments

Table 53. BioMerieux Company Information, Head Office, Market Area and Industry Position

Table 54. BioMerieux Company Profile and Main Business

Table 55. BioMerieux Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 56. BioMerieux Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 57. BioMerieux Recent Developments

Table 58. Co-Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 59. Co-Diagnostics Company Profile and Main Business

Table 60. Co-Diagnostics Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 61. Co-Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 62. Co-Diagnostics Recent Developments

Table 63. DanaherCorporation Company Information, Head Office, Market Area and Industry Position

Table 64. DanaherCorporation Company Profile and Main Business

Table 65. DanaherCorporation Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 66. DanaherCorporation Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 67. DanaherCorporation Recent Developments

Table 68. Dako Company Information, Head Office, Market Area and Industry Position

Table 69. Dako Company Profile and Main Business

Table 70. Dako Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 71. Dako Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 72. Dako Recent Developments

Table 73. F. Hoffmann Company Information, Head Office, Market Area and Industry Position

Table 74. F. Hoffmann Company Profile and Main Business

Table 75. F. Hoffmann Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 76. F. Hoffmann Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 77. F. Hoffmann Recent Developments

Table 78. OraSure Technologies Company Information, Head Office, Market Area and Industry Position

Table 79. OraSure Technologies Company Profile and Main Business

Table 80. OraSure Technologies Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 81. OraSure Technologies Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 82. OraSure Technologies Recent Developments

Table 83. Roche Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 84. Roche Diagnostics Company Profile and Main Business

Table 85. Roche Diagnostics Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 86. Roche Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 87. Roche Diagnostics Recent Developments

Table 88. Nipro Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 89. Nipro Diagnostics Company Profile and Main Business

Table 90. Nipro Diagnostics Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 91. Nipro Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 92. Nipro Diagnostics Recent Developments

Table 93. Genestat Company Information, Head Office, Market Area and Industry Position

Table 94. Genestat Company Profile and Main Business

Table 95. Genestat Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 96. Genestat Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 97. Genestat Recent Developments

Table 98. Meridian Bioscience Company Information, Head Office, Market Area and Industry Position

Table 99. Meridian Bioscience Company Profile and Main Business

Table 100. Meridian Bioscience Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 101. Meridian Bioscience Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 102. Meridian Bioscience Recent Developments

Table 103. Molbio Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 104. Molbio Diagnostics Company Profile and Main Business

Table 105. Molbio Diagnostics Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 106. Molbio Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 107. Molbio Diagnostics Recent Developments

Table 108. Siemens Healthcare Company Information, Head Office, Market Area and Industry Position

Table 109. Siemens Healthcare Company Profile and Main Business

Table 110. Siemens Healthcare Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 111. Siemens Healthcare Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 112. Siemens Healthcare Recent Developments

Table 113. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position

Table 114. Thermo Fisher Scientific Company Profile and Main Business

Table 115. Thermo Fisher Scientific Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 116. Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 117. Thermo Fisher Scientific Recent Developments

Table 118. Visby Medical Company Information, Head Office, Market Area and Industry Position

Table 119. Visby Medical Company Profile and Main Business

Table 120. Visby Medical Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 121. Visby Medical Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 122. Visby Medical Recent Developments

Table 123. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Company Information, Head Office, Market Area and Industry Position

Table 124. Wuhan Easy Diagnosis Biomedicine Company Profile and Main Business

Table 125. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 126. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 127. Wuhan Easy Diagnosis Biomedicine Recent Developments

Table 128. Beijing Tiandz Company Information, Head Office, Market Area and Industry Position

Table 129. Beijing Tiandz Company Profile and Main Business

Table 130. Beijing Tiandz Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 131. Beijing Tiandz Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 132. Beijing Tiandz Recent Developments

Table 133. Beijing Content Company Information, Head Office, Market Area and Industry Position

Table 134. Beijing Content Company Profile and Main Business

Table 135. Beijing Content Molecular Diagnostics Point of Care Models, Specifications, and Application

Table 136. Beijing Content Molecular Diagnostics Point of Care Revenue and Gross Margin, US$ Million, 2018-2023

Table 137. Beijing Content Recent Developments

List of Figures

Figure 1. Molecular Diagnostics Point of Care Picture

Figure 2. Global Molecular Diagnostics Point of Care Consumption Value, (US$ million) & (2018-2029)

Figure 3. China Molecular Diagnostics Point of Care Consumption Value, (US$ million) & (2018-2029)

Figure 4. By Consumption Value, China Molecular Diagnostics Point of Care Market Share of Global, 2018-2029

Figure 5. Global Molecular Diagnostics Point of Care Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 6. China Molecular Diagnostics Point of Care Key Participants, Market Share, 2022

Figure 7. Molecular Diagnostics Point of Care Industry Chain

Figure 8. Molecular Diagnostics Point of Care Procurement Model

Figure 9. Molecular Diagnostics Point of Care Sales Model

Figure 10. Molecular Diagnostics Point of Care Sales Channels, Direct Sales, and Distribution

Figure 11. Assays and Kits

Figure 12. Instruments and Analyzers

Figure 13. Software and Services

Figure 14. Others

Figure 15. By Type, Global Molecular Diagnostics Point of Care Consumption Value, 2018-2029, US$ Million

Figure 16. By Type, Global Molecular Diagnostics Point of Care Consumption Value Market Share, 2018-2029

Figure 17. Tumor

Figure 18. Hematology

Figure 19. Endocrinology

Figure 20. Infectious Disease

Figure 21. Others

Figure 22. By Application, Global Molecular Diagnostics Point of Care Consumption Value, 2018-2029, US$ Million

Figure 23. By Application, Global Molecular Diagnostics Point of Care Consumption Value Market Share, 2018-2029

Figure 24. By Region, Global Molecular Diagnostics Point of Care Consumption Value Market Share, 2018-2029

Figure 25. North America Molecular Diagnostics Point of Care Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 26. By Country, North America Molecular Diagnostics Point of Care Consumption Value Market Share, 2022

Figure 27. Europe Molecular Diagnostics Point of Care Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, Europe Molecular Diagnostics Point of Care Consumption Value Market Share, 2022

Figure 29. Asia Pacific Molecular Diagnostics Point of Care Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 30. By Country/Region, Asia Pacific Molecular Diagnostics Point of Care Consumption Value Market Share, 2022

Figure 31. South America Molecular Diagnostics Point of Care Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 32. By Country, South America Molecular Diagnostics Point of Care Consumption Value Market Share, 2022

Figure 33. Middle East & Africa Molecular Diagnostics Point of Care Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 34. U.S. Molecular Diagnostics Point of Care Consumption Value, 2018-2029, US$ Million

Figure 35. By Type, U.S. Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 36. By Application, U.S. Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 37. Europe Molecular Diagnostics Point of Care Consumption Value, 2018-2029, US$ Million

Figure 38. By Type, Europe Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 39. By Application, Europe Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 40. China Molecular Diagnostics Point of Care Consumption Value, 2018-2029, US$ Million

Figure 41. By Type, China Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 42. By Application, China Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 43. Japan Molecular Diagnostics Point of Care Consumption Value, 2018-2029, US$ Million

Figure 44. By Type, Japan Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 45. By Application, Japan Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 46. South Korea Molecular Diagnostics Point of Care Consumption Value, 2018-2029, US$ Million

Figure 47. By Type, South Korea Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 48. By Application, South Korea Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 49. Southeast Asia Molecular Diagnostics Point of Care Consumption Value, 2018-2029, US$ Million

Figure 50. By Type, Southeast Asia Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 51. By Application, Southeast Asia Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 52. India Molecular Diagnostics Point of Care Consumption Value, 2018-2029, US$ Million

Figure 53. By Type, India Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 54. By Application, India Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 55. Middle East & Africa Molecular Diagnostics Point of Care Consumption Value, 2018-2029, US$ Million

Figure 56. By Type, Middle East & Africa Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 57. By Application, Middle East & Africa Molecular Diagnostics Point of Care Consumption Value Market Share, 2022 VS 2029

Figure 58. Research Methodology

Figure 59. Breakdown of Primary Interviews

Figure 60. Bottom-up and Top-down Approaches

Figure 61. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)